OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Hamlet Gasoyan, Elizabeth R. Pfoh, Rebecca Schulte, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2433326-e2433326
Open Access | Times Cited: 13

Showing 13 citing articles:

Sleeve Gastrectomy Versus Semaglutide for Weight Loss in a Severely Obese Minority Cohort: A Propensity-Matched Study
Mario Masrur, Emiliano G. Manueli Laos, Lily Zhang, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1

Glucagon‐like peptide‐1 receptor agonists discontinuation is higher in individuals with overweight and obesity without type 2 diabetes
Gregory J. Grosicki, J. Graham Thomas, Nikhil V. Dhurandhar, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

Greater improvement in insulin sensitivity per unit weight loss associated with tirzepatide versus semaglutide: An exploratory analysis
Kieren J. Mather, Andrea Mari, Govinda J. Weerakkody, et al.
Diabetes Obesity and Metabolism (2025) Vol. 27, Iss. 3, pp. 1507-1514
Closed Access

Tratamiento actual de la obesidad: una historia sobre creencias, apegos y confrontación
José M. Balibrea, María Recarte-Rico, María Dolores Frutos
Cirugía Española (2025)
Closed Access

Liraglutide Treatment Restores Cardiac Function After Isoprenaline-Induced Myocardial Injury and Prevents Heart Failure in Rats
Zorislava Bajić, Tanja Šobot, Aleksandra Šmitran, et al.
Life (2025) Vol. 15, Iss. 3, pp. 443-443
Open Access

Older Adults’ Views on Insurance Coverage for Weight Management Medications
Lauren Oshman, Matthias Kirch, Erica Solway, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e252008-e252008
Open Access

Investigating the Impact of GLP-1 Receptor Agonist-Induced Fat Loss on Collagen Synthesis and Skin Elasticity
Alejandra Sataray-Rodriguez, Donna Pham, Ceilia Severini, et al.
Journal of Biomedical Science and Engineering (2025) Vol. 18, Iss. 03, pp. 45-59
Open Access

Avances farmacológicos en la lucha contra la obesidad
Pablo Caballero Portero
Panorama actual del medicamento (2025) Vol. 49, Iss. 481, pp. 154-182
Closed Access

Current perspectives on the use of GLP-1 receptor agonists in obesity-related obstructive sleep apnea: a narrative review
Ali El-Solh, Erin Gould, Keziah Aibangbee, et al.
Expert Opinion on Pharmacotherapy (2024)
Closed Access | Times Cited: 2

Influence of BMI-associated genetic variants and metabolic risk factors on weight loss with semaglutide: a longitudinal clinico-genomic cohort study
Matthew E. Levy, Natalie Telis, Kelly M. Schiabor Barrett, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Page 1

Scroll to top